Journal article
Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors.
- Abstract:
-
Persistence of human immunodeficiency virus (HIV) in a latent state in long-lived CD4+ T-cells is a major barrier to eradication. Latency-reversing agents that induce direct or immune-mediated cell death upon reactivation of HIV are a possible solution. However, clearance of reactivated cells may require immunotherapeutic agents that are fine-tuned to detect viral antigens when expressed at low levels. We tested the antiviral efficacy of immune-mobilizing monoclonal T-cell receptors against v...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
NIHR Oxford Biomedical Research Centre
More from this funder
Bibliographic Details
- Publisher:
- Nature Publishing Group Publisher's website
- Journal:
- Mol Ther Journal website
- Publication date:
- 2016-07-12
- Acceptance date:
- 2016-05-24
- DOI:
- EISSN:
-
1525-0024
- ISSN:
-
1525-0016
- Source identifiers:
-
633896
Item Description
- Language:
- English
- Pubs id:
-
pubs:633896
- UUID:
-
uuid:42207a3c-4604-4149-b94c-f83bdedfea0e
- Local pid:
- pubs:633896
- Deposit date:
- 2016-07-13
Terms of use
- Copyright holder:
- Yang et al
- Copyright date:
- 2016
- Notes:
- Author(s) retain copyright; published by Nature Publishing Group under license. Molecular Therapy is the official journal of the American Society of Gene and Cell Therapy. This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
If you are the owner of this record, you can report an update to it here: Report update to this record